Literature DB >> 6321759

Organization of the left-hand end of the herpes simplex virus type 2 BglII N fragment.

D A Galloway, M A Swain.   

Abstract

We have determined the complete nucleotide sequence surrounding the region coding for a 38,000-dalton protein of herpes simplex virus type 2 strain 333 that is encoded between map coordinates 0.58 to 0.595 on the viral genome. The sequence data have revealed an open translational reading frame of 1,011 nucleotides encoding a protein of 337 amino acids. Upstream of those sequences, transcriptional regulatory signals could be identified that overlap another open reading frame of 489 nucleotides, which presumably encodes the carboxy-terminal 163 amino acids of a 140,000-dalton protein. Downstream of the gene encoding the 38,000-dalton protein a polyadenylation signal was found as well as one further along on the other strand near a termination codon that presumably punctuates the gene specifying a 61,000-dalton protein. The DNA sequence data were compared with the amended sequence of the herpes simplex virus type 1 strain KOS 40,000-dalton protein (K. G. Draper, R. F. Frink, and E. K. Wagner, J. Virol. 43:1123-1128, 1982) and with the 5' end of the same gene from herpes simplex virus type 1 strain 17 (J. McLaughlan and J. B. Clements, J. Gen. Virol. 64:997-1006, 1983) to assess the degree of inter- and intratypic variation. The comparison of the sequences has provided a basis for the type specifity of this viral protein and for different mechanisms giving rise to the diversity between herpes simplex virus types 1 and 2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321759      PMCID: PMC255530     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.

Authors:  F Sanger; A R Coulson
Journal:  J Mol Biol       Date:  1975-05-25       Impact factor: 5.469

2.  Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2.

Authors:  R J Jariwalla; L Aurelian; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

3.  A fast and simple method for sequencing DNA cloned in the single-stranded bacteriophage M13.

Authors:  P H Schreier; R Cortese
Journal:  J Mol Biol       Date:  1979-03-25       Impact factor: 5.469

4.  Further procedures for sequence analysis by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1978-03       Impact factor: 16.971

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  A control region in the center of the 5S RNA gene directs specific initiation of transcription: I. The 5' border of the region.

Authors:  S Sakonju; D F Bogenhagen; D D Brown
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

7.  Computer programs for the assembly of DNA sequences.

Authors:  T R Gingeras; J P Milazzo; D Sciaky; R J Roberts
Journal:  Nucleic Acids Res       Date:  1979-09-25       Impact factor: 16.971

8.  Sequence data handling by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  DNA sequence homology between two co-linear loci on the HSV genome which have different transforming abilities.

Authors:  J McLauchlan; J B Clements
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  18 in total

1.  Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10.

Authors:  C C Smith; J P Wymer; J Luo; L Aurelian
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

2.  Herpes simplex virus specifies two subunits of ribonucleotide reductase encoded by 3'-coterminal transcripts.

Authors:  M A Swain; D A Galloway
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2.

Authors:  E A Cohen; P Gaudreau; P Brazeau; Y Langelier
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart.

Authors:  M A Swain; R W Peet; D A Galloway
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product.

Authors:  Y Hayashi; T Iwasaka; C C Smith; L Aurelian; G K Lewis; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures.

Authors:  D A Galloway; J A Nelson; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  DNA sequence and RNA transcription through a site of recombination in a non-neurovirulent herpes simplex virus intertypic recombinant.

Authors:  R L Thompson; G V Devi-Rao; E K Wagner
Journal:  Virus Genes       Date:  1988-06       Impact factor: 2.332

8.  Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior.

Authors:  G A Gentry; M Lowe; G Alford; R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Characterization of mRNAs that map in the BglII N fragment of the herpes simplex virus type 2 genome.

Authors:  F J Jenkins; M K Howett
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Herpes simplex virus types 1 and 2 homology in the region between 0.58 and 0.68 map units.

Authors:  K G Draper; R J Frink; G B Devi; M Swain; D Galloway; E K Wagner
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.